Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;85(3):237-9.
doi: 10.1038/clpt.2008.258.

Adding a medicine to the WHO model list of essential medicines

Affiliations

Adding a medicine to the WHO model list of essential medicines

S P Kishore et al. Clin Pharmacol Ther. 2009 Mar.

Abstract

Although the concept of essential medicines is not new, the processes that lead to placement of these medicines on the World Health Organization Model List of Essential Medicines are not well understood. Here, we describe the process by which we added a class of drugs, statins, to the Model List to help combat the growing global epidemic of cardiovascular disease.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declared no conflict of interest.

Figures

Figure 1
Figure 1
Adding statins to the 15th WHO Model List of Essential Medicines. The key events in our bid to have statins listed are highlighted. The formal application form to add or delete an essential medicine is available at http://www.who.int/medicines/publications/essentialmedicines. Our complete submission can be viewed at http://archives.who.int/eml/expcom/expcom15/applications/newmed/statins/statins.pdf. CeVEAS, Centre for the Evaluation of the Effectiveness of Health Care (Modena, Italy); EML, Essential Medicines List; WHO, World Health Organization.

References

    1. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112:3547–3553. - PubMed
    1. World Health Organization. Shaping the Future. World Health Organization; Geneva: 2003.
    1. Schwartlander B, Grubb I, Perriens J. The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world. Lancet. 2006;368:541–546. - PubMed
    1. Zhang X, Patel A, Horibe H, Wu Z, Barzi F, Rodgers A, et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol. 2003;32:563–572. - PubMed
    1. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA. 1995;274:131–136. - PubMed

Publication types

MeSH terms

Substances